TuHURA BIOSCIENCES, INC./NV Shareholders' Equity
TuHURA BIOSCIENCES, INC./NV (HURA) had Shareholders' Equity of $18.50 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $18.50M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $23.19M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $20.93M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $16.78M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $18.50M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $23.19M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $20.93M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $16.78M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $19.45M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $9.86M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $14.59M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$2.77M 10-Q · filed 2025-11-14 | $1.70M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$6.96M 10-Q · filed 2025-11-14 | $3.76M 10-K · filed 2024-10-07 |
| 2024-03-31 | -$6.07M 10-Q · filed 2025-11-14 | $5.92M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$1.56M 10-K · filed 2026-03-31 | -$164.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | -$2.03M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $731.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $3.79M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $12.30M 10-K · filed 2025-03-31 | $6.60M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $9.62M 10-Q · filed 2024-05-14 | |
| 2022-06-30 | $11.79M 10-K · filed 2024-10-07 | |
| 2022-03-31 | $9.39M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $14.10M 10-Q · filed 2023-05-11 | |
| 2021-09-30 | $19.16M 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $10.58M 10-K · filed 2023-09-18 | |
| 2021-03-31 | $16.12M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $17.59M 10-Q · filed 2022-05-13 | |
| 2020-09-30 | $20.55M 10-Q · filed 2022-05-13 | |
| 2020-06-30 | $263.00K 10-K · filed 2022-09-27 | $263.21K 10-K · filed 2020-09-18 |
| 2020-03-31 | $3.72M 10-Q · filed 2021-05-13 | $3.72M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $5.48M 10-Q · filed 2021-05-13 | $5.48M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $7.03M 10-Q · filed 2021-05-13 | $7.02M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $1.97M 10-K · filed 2021-09-28 | $1.97M 10-K · filed 2019-09-09 |
| 2019-03-31 | $1.26M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $2.77M 10-Q · filed 2020-05-13 | |
| 2018-09-30 | $3.67M 10-Q · filed 2020-05-13 | |
| 2018-06-30 | $5.44M 10-K · filed 2020-09-18 | |
| 2018-03-31 | $7.66M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $9.98M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $12.92M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $6.58M 10-K · filed 2019-09-09 | |
| 2017-03-31 | $1.23M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $2.70M 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $3.97M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $4.86M 8-K · filed 2019-06-03 | |
| 2016-03-31 | -$687.60K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $116.73K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | -$514.51K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$821.49K 10-K · filed 2017-09-27 | $511.89K 10-K · filed 2015-09-03 |
| 2015-03-31 | $1.22M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $2.09M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $520.94K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$901.16K 10-K · filed 2016-09-13 | $880.48K 10-K · filed 2014-08-28 |
| 2014-03-31 | -$3.06M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$817.98K 10-K · filed 2014-08-28 | |
| 2013-09-30 | -$304.30K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$12.83M 10-K · filed 2015-11-16 | -$7.71M 10-Q · filed 2013-08-12 |
| 2013-03-31 | -$2.02M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$1.33M 10-K · filed 2014-08-28 | -$15.60K 10-Q · filed 2013-01-18 |
| 2012-09-30 | -$12.35K 10-Q/A · filed 2012-12-20 | |
| 2012-06-30 | -$8.19K 10-Q · filed 2013-01-18 | |
| 2012-03-31 | -$7.21K 10-Q/A · filed 2012-06-05 | |
| 2011-12-31 | -$877.13K 10-K · filed 2014-08-28 | -$4.08K 10-Q · filed 2012-02-07 |
| 2011-09-30 | $6.84K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $10.70K 10-K/A · filed 2012-12-20 | |
| 2010-12-31 | -$1.52K 10-K · filed 2014-08-28 | |
| 2010-06-30 | $43.91K 10-K/A · filed 2012-12-20 | |
| 2009-06-23 | $0.00 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |